Clinical trial
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT00167219 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00167219 |
|---|---|
| Title | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) |
| Official title | Hematopoietic Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Juvenile Myelomonocytic Leukemia |
| Intervention type | Biological, Drug |
| Interventions | Stem Cell Transplant, Preparative Regimen |
| Enrollment | 15 |
| Start date | Nov 18, 1999 |
| Primary completion | Jul 12, 2022 |
| Completion | Aug 9, 2023 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 7, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: